CD276 and head and neck squamous cell carcinoma: Very recently, we identified that CSCs utilized the immune checkpoint molecule CD276 (B7-H3), but PD-1 (also known as CD274 or B7-H1), to evade immune surveillance in a 4-nitroquinoline 1-oxide-induced mouse HNSCC.